Company Filing History:
Years Active: 2014
Title: Innovations in Drug Delivery: The Contributions of Rajendra Ghanshamlal Lala
Introduction
Rajendra Ghanshamlal Lala is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. His innovative approach has led to the development of a novel drug delivery system that enhances patient convenience and cost-effectiveness.
Latest Patents
Lala holds a patent for a process of manufacturing a novel drug delivery system, specifically a multilayer tablet composition of thiazolidinedione and biguanides. This pharmaceutical composition is designed for controlling hyperglycemia and allows for the immediate release of thiazolidinediones or thiazolidinediones and biguanide, along with a prolonged release of biguanide. The tablet consists of at least two layers, with one outer layer containing a mixture of excipients and thiazolidinediones, facilitating immediate release. The inner layer, in contact with the immediate release layer, comprises a unique composition of excipients and non-biodegradable, inert polymers, enabling a pH-independent prolonged release of biguanide for up to 8-12 hours. This innovative tablet formulation is intended for once-a-day dosing and may be film-coated or enrobed for additional protection and aesthetic appeal.
Career Highlights
Rajendra Ghanshamlal Lala is associated with Inventia Healthcare Private Limited, where he continues to contribute to advancements in pharmaceutical technology. His work focuses on creating effective drug delivery systems that improve patient outcomes.
Collaborations
Lala collaborates with talented professionals in his field, including Amit Krishna Antarkar and Nirav Mahendra Kamdar. Their combined expertise fosters an environment of innovation and progress in pharmaceutical research.
Conclusion
Rajendra Ghanshamlal Lala's contributions to drug delivery systems exemplify the importance of innovation in the pharmaceutical industry. His patented multilayer tablet composition represents a significant advancement in the management of hyperglycemia, showcasing the potential for improved patient care through innovative drug formulations.